During the past decade, Via Christi Research conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 14 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Via Christi Research" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Indivior Inc." with 2 trials sponsored and "AstraZeneca" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Via Christi Research" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Banner Alzheimer's Institute" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Via Christi Research" are "Schizophrenia" (6 trials), "Alzheimer Disease" (5 trials), "Alzheimer's Disease" (2 trials), "Alzheimers Disease" (2 trials) and "Crohn Disease" (2 trials). Many other conditions were trialed in "Via Christi Research" in a lesser frequency.

Most popular intervention types in "Via Christi Research" are "Drug" (32 trials), "Other" (5 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "GED-0301" (3 trials), "Gantenerumab" (3 trials), "placebo" (3 trials) and "RBP-7000" (2 trials). Other intervention names were less common.

The vast majority of trials in "Via Christi Research" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Via Christi Research". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Via Christi Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Via Christi Research, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Via Christi Research has several departments that took part in Clinical trials: "Via Christi Comprehensive Epilepsy Center" - 4 trials